-
Mashup Score: 1
In a new series by the CNBC personal finance team, we’re delving into how climate change will impact your money.
Source: www.cnbc.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 1
The enormous potential for generative pretrained transformers (GPTs) and other artificial intelligence (AI) large language models (LLMs) to improve health care has become increasingly clear. Softwa…
Source: ai.nejm.orgCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 1Numbers are up: IVF births and egg-freezing cycles - 3 hour(s) ago
In 2022, 2.5% of all U.S. births were a result of IVF, per new SART data.
Source: www.axios.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 2The ‘Ten Commandments’ for the 2023 European Society of Cardiology guidelines for the management of endocarditis - 15 hour(s) ago
The 2023 European Society of Cardiology (ESC) Guidelines for the Management of Endocarditis were developed by the ESC Endocarditis Task Force, which consis
Source: academic.oup.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 1
On a recent Saturday, some 100 volunteers gathered on a popular beach in the Japanese port city of Yokohama, wading in the shallows to plant strands of light-green eelgrass on the seabed.
Source: www.reuters.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 0Sarcopenia and aortic valve disease - 2 day(s) ago
Valvular heart disease, including calcific or degenerative aortic stenosis (AS), is increasingly prevalent among the older adult population. Over the last few decades, treatment of severe AS has been revolutionised following the development of transcatheter aortic valve replacement (TAVR). Despite improvements in outcomes, older adults with competing comorbidities and geriatric syndromes have suboptimal quality of life outcomes, highlighting the cumulative vulnerability that persists despite valve replacement. Sarcopenia, characterised by loss of muscle strength, mass and function, affects 21%–70% of older adults with AS. Sarcopenia is an independent predictor of short-term and long-term outcomes after TAVR and should be incorporated as a prognostic marker in preprocedural planning. Early diagnosis and treatment of sarcopenia may reduce morbidity and mortality and improve quality of life following TAVR. The adverse effects of sarcopenia can be mitigated through resistance training and
Source: heart.bmj.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 3Aortic aneurysms in a general population cohort: prevalence and risk factors in men and women - 2 day(s) ago
This study explores two critical hypotheses: i) that the prevalence of thoracic and abdominal aortic aneurysms differs between men and women in a general p
Source: academic.oup.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 1Listen to Autentica 107.5 fm - 2 day(s) ago
Listen to Autentica 107.5 fm for the best Spanish (Venezuela) Music radio. Listen live, catch up on old episodes and keep up to date with announcements.
Source: Zeno.FMCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 1BioAro Announces a Medical and Computing Breakthrough by Launching the 'World's Fastest' Real-Time Genomic Software 'PanOmiQ' - 2 day(s) ago
PanOmiQ completes Whole Genome Sequencing analysis with a clinical report in 7 hours. CALGARY, AB, April 25, 2024 /PRNewswire/ – BioAro, a pioneer in genomic research and technology, is set to officially launch
Source: www.benzinga.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 0Sarcopenia and aortic valve disease - 2 day(s) ago
Valvular heart disease, including calcific or degenerative aortic stenosis (AS), is increasingly prevalent among the older adult population. Over the last few decades, treatment of severe AS has been revolutionised following the development of transcatheter aortic valve replacement (TAVR). Despite improvements in outcomes, older adults with competing comorbidities and geriatric syndromes have suboptimal quality of life outcomes, highlighting the cumulative vulnerability that persists despite valve replacement. Sarcopenia, characterised by loss of muscle strength, mass and function, affects 21%–70% of older adults with AS. Sarcopenia is an independent predictor of short-term and long-term outcomes after TAVR and should be incorporated as a prognostic marker in preprocedural planning. Early diagnosis and treatment of sarcopenia may reduce morbidity and mortality and improve quality of life following TAVR. The adverse effects of sarcopenia can be mitigated through resistance training and
Source: heart.bmj.comCategories: General Medicine News, Cardiologists1Tweet
Climate change could cost Americans born in 2024 nearly $500,000 in their lifetime https://t.co/sdw3HDW2Np